- Home
- SMTI vs AVIR Comparison
SMTI vs AVIR Comparison
Compare SMTI & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMTI | AVIR |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.9M | 236.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SMTI | AVIR |
|---|---|---|
| Price | $24.67 | $3.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $41.00 | $6.00 |
| AVG Volume (30 Days) | 43.0K | ★ 362.8K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $101,877,532.00 | N/A |
| Revenue This Year | $21.60 | N/A |
| Revenue Next Year | $16.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.52 | N/A |
| 52 Week Low | $18.90 | $2.46 |
| 52 Week High | $38.68 | $4.02 |
Technical Indicators
Market Signals| Indicator | SMTI | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 53.32 | 73.01 |
| Support Level | $24.00 | $3.11 |
| Resistance Level | $25.41 | $3.27 |
| Average True Range (ATR) | 1.17 | 0.12 |
| MACD | 0.34 | 0.04 |
| Stochastic Oscillator | 55.71 | 88.52 |
Price Performance
Historical ComparisonAbout SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).